CStone Pharmaceuticals (2616.HK)

HKD 2.39

(-6.64%)

Net Income Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual net income in 2023 was -367.23 Million CNY , up 61.93% from previous year.
CStone Pharmaceuticals's latest quarterly net income in 2024 Q1 was 7.84 Million CNY , up 109.94% from previous quarter.
CStone Pharmaceuticals reported an annual net income of -964.6 Million CNY in 2022, up 51.47% from previous year.
CStone Pharmaceuticals reported an annual net income of -1.98 Billion CNY in 2021, down -62.92% from previous year.
CStone Pharmaceuticals reported a quarterly net income of 7.84 Million CNY for 2024 Q1, up 109.94% from previous quarter.
CStone Pharmaceuticals reported a quarterly net income of -367.23 Million CNY for 2023 FY, up 61.93% from previous quarter.

Annual Net Income Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Net Income of CStone Pharmaceuticals (2023 - 2016)

Year	Net Income	Net Income Growth
2023	-367.23 Million CNY	61.93%
2022	-964.6 Million CNY	51.47%
2021	-1.98 Billion CNY	-62.92%
2020	-1.21 Billion CNY	60.09%
2019	-3.05 Billion CNY	-75.15%
2018	-1.74 Billion CNY	-464.99%
2017	-308.9 Million CNY	-25.52%
2016	-246.09 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	7.84 Million CNY	0.0%
2024 Q1	7.84 Million CNY	109.94%
2023 FY	-367.23 Million CNY	61.93%
2023 Q1	-104.61 Million CNY	61.33%
2023 Q3	-79 Million CNY	24.48%
2023 Q2	-104.61 Million CNY	0.0%
2023 Q4	-79 Million CNY	0.0%
2022 Q4	-270.55 Million CNY	0.0%
2022 FY	-964.6 Million CNY	51.47%
2022 Q3	-270.55 Million CNY	-49.66%
2022 Q2	-180.78 Million CNY	0.0%
2022 Q1	-180.78 Million CNY	68.46%
2021 Q4	-573.12 Million CNY	0.0%
2021 Q3	-573.12 Million CNY	-48.12%
2021 FY	-1.98 Billion CNY	-62.92%
2021 Q1	-386.92 Million CNY	-40.76%
2021 Q2	-386.92 Million CNY	0.0%
2020 Q2	-335.62 Million CNY	0.0%
2020 Q3	-274.87 Million CNY	18.1%
2020 FY	-1.21 Billion CNY	60.09%
2020 Q4	-274.87 Million CNY	0.0%
2020 Q1	-335.62 Million CNY	37.42%
2019 Q3	-536.32 Million CNY	-7.69%
2019 FY	-3.05 Billion CNY	-75.15%
2019 Q4	-536.32 Million CNY	0.0%
2019 Q1	-498.04 Million CNY	27.13%
2019 Q2	-498.04 Million CNY	0.0%
2018 Q1	-109.8 Million CNY	-44.96%
2018 FY	-1.74 Billion CNY	-464.99%
2018 Q4	-683.51 Million CNY	27.88%
2018 Q3	-947.72 Million CNY	-763.1%
2018 Q2	-109.8 Million CNY	0.0%
2017 FY	-308.9 Million CNY	-25.52%
2017 Q4	-75.74 Million CNY	0.0%
2016 FY	-246.09 Million CNY	0.0%

Peer Net Income Comparison of CStone Pharmaceuticals

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	618.136%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	2228.893%